Objectives This study sought to evaluate the long-term clinical outcomes of a fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) strategy compared with intravascular ultrasound (IVUS)-guided PCI for intermediate coronary lesions.
Because of the limitations of coronary angiography (1) , adjunctive techniques to more accurately evaluate lesion severity are important in patients with intermediate coronary stenosis before percutaneous coronary intervention (PCI). Fractional flow reserve (FFR) has been the reference standard for the physiological assessment of coronary artery stenosis, particularly intermediate ones (2) (3) (4) . Deferring intervention of intermediate coronary lesions with a FFR Ն0.75 or 0.80 is associated with favorable long-term clinical outcomes (5, 6 ). An intravascular ultrasound (IVUS)- An intermediate coronary lesion was defined as 40% to 70% diameter stenosis by visual assessment. For this study, the target vessel was a single lesion in the proximal or mid part of a major epicardial coronary artery with reference vessel diameter larger than 2.5 mm. The lesion had no documented evidence of ischemia by noninvasive tests (not performed, negative, inadequate, or not evaluable for a target lesion). Patients were not eligible for enrollment if they: 1) had undergone intervention in the setting of primary or emergent PCI for an acute coronary syndrome; 2) had prior coronary artery bypass graft surgery; 3) had multiple lesions in the same epicardial artery; 4) had left main disease, primary myocardial disease, or a major life threatening illness; or 5) had contraindications to adenosine, aspirin, or clopidogrel.
The use of FFR or IVUS was made based on operator preference. The cutoff value of FFR in the FFR-guided PCI group was 0.80 (6, 9, 10) and that of MLA in the IVUSguided PCI was 4.0 mm 2 (7, 8) . Implanted stents were commercially available drug-eluting stents (DES) in all cases. Procedural details. Coronary angiography was performed in multiple views after the intracoronary injection of 0.2 mg nitroglycerin. Percutaneous coronary intervention was performed following standard interventional techniques. Antiplatelet and antithrombotic agents were prescribed according to current PCI guidelines (3). All coronary angiograms were analyzed using standard definitions and measurements by quantitative coronary angiography (Quantcor QCA, version 4.0, Pie Medical Imaging, Maastricht, the Netherlands) by an experienced physician who was blinded to the type of PCI guidance.
Fractional flow reserve was defined as the ratio between mean distal coronary pressure and mean aortic pressure, both measured simultaneously at maximal hyperemia. Coronary pressure was measured using a 0.014-inch sensortipped PCI guidewire (Pressure Wire, Radi Medical Systems, Uppsala, Sweden). The wire was introduced through a 6-or 7-F guiding catheter, equalized, and advanced distal to the stenosis as previously described (9) . The FFR value was checked after administration of adenosine to induce maximal hyperemia, either intravenously (140 g/kg/min) or intracoronarily (40 g in the right, 80 g in the left coronary artery).
Intravascular ultrasound guidance was performed using conventional 6-or 7-F guiding catheters and a 0.014-mm guidewire positioned distally, and IVUS catheters of 30 or 40 MHz (Boston Scientific Corp., Natick, Massachusetts) pulled back automatically at a constant speed of 0.5 mm/s. The lesion site selected for analysis was the image slice with MLA and minimal stent area, which were measured following the guidelines for IVUS measurements by the American College of Cardiology (11) . Definitions and study outcomes. The primary outcome was defined as a composite of major adverse cardiac events (MACE), defined as death, myocardial infarction, and ischemia-driven target vessel revascularization (TVR) at 12 months after the index procedure. Death was defined as all-cause mortality. The diagnosis of myocardial infarction was based on either the development of new pathological Q waves in Ն2 contiguous electrocardiogram leads and/or cardiac enzyme level elevation Ͼ3 times the upper limit of normal value. TVR included target lesion PCI and bypass surgery of the target lesion. TVR was performed only in the presence of symptoms and/or signs of ischemia. Stent thrombosis was defined according to the Academic Research Consortium guidelines (12) . Statistical analyses. Data are expressed as mean Ϯ SD for continuous variables and as percentages for discrete vari- 
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ables. Continuous variables were compared using Student t test. Categorical variables were compared using chi-square tests or Fisher exact test, as appropriate. All calculated p values were 2-sided and differences were considered to be statistically significant when the respective p values were Ͻ0.05. Multivariate logistic regression analysis was used to assess independent predictors of performing PCI and of MACE. The parameters analyzed in multivariate analysis were selected when p value was lesser than 0.5 in univariate analysis. All statistical analyses were performed using SPSS version 15.0 for Windows (SPSS Inc., Chicago, Illinois).
Results
Baseline clinical, angiographic, and procedural characteristics are summarized in Tables 1 and 2 . Among 167 consecutive patients (177 lesions), 83 lesions were assessed by FFR and 94 lesions by IVUS. Intracoronary adenosine was used in 79 lesions to induce maximal hyperemia. The resulting groups were well matched without significant differences in the frequency of clinical cardiovascular risk factors. The incidence of multivessel disease was significantly higher in the FFR group (66.3% vs. 48.9%, p ϭ 0.02). The most common target lesion location was the left anterior descending coronary artery (LAD) in both groups (48.2% in the FFR group vs. 58.8% in the IVUS group, p ϭ 0.18). There was no significant difference in clinical presentation. Both groups had similar percent diameter stenosis (51 Ϯ 8% vs. 52 Ϯ 8% in the FFR and IVUS groups respectively, p ϭ 0.53). However, reference vessel diameter was larger in the IVUS-guided group (3.39 Ϯ 0.49 mm vs. 3.23 Ϯ 0.43 mm, p ϭ 0.03). Although angiographic lesion length was similar between 2 groups, IVUS lesion length was slightly longer than angiographic lesion length in IVUS group (23.5 Ϯ 12.7 mm in angiographic lesion length vs. 25.3 Ϯ 11.0 mm in IVUS lesion length, p ϭ 0.008). The incidence of performing PCI was much lower in the FFR-guided group (33.7% vs. 91.5%, p Ͻ0.001) as shown in Figure 1 . The mean FFR value of deferred lesions was 0.87 Ϯ 0.06 whereas that of revascularized lesions was 0.72 Ϯ 0.07 in the FFR-guided group. The mean MLA of deferred lesions was 5.1 Ϯ 1.5 mm 2 and that of lesions treated by PCI was 2.9 Ϯ 0.9 mm 2 in the IVUS-guided group (Table 2) . When evaluating LAD lesions alone, the frequency of PCI continued to be greater with IVUS guidance compared with FFR guidance (52.5% in FFR group vs. 90.9% in IVUS group, p Ͻ 0.001).
The 12-month clinical outcomes are summarized in Figure 2 . There were no significant differences in TVR (3.6% in FFR group vs. 2.1% in the IVUS group, p ϭ 0.67) Values are mean Ϯ SD.
DS ϭ percent diameter stenosis; MLA ϭ minimal lumen diameter; MLD ϭ minimal lumen diameter; MSA ϭ minimal stent area; other abbreviations as in Table 1 .
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and MACE (3.6% in FFR group vs. 3.2% in IVUS group, p ϭ 1.00) between the 2 groups. The 3 TVR cases in the FFR-guided group were due to in-stent restenosis, deferred lesion aggravation, and progression of a nontarget lesion. The 2 TVR cases in the IVUS-guided group were secondary to in-stent restenosis. One noncardiac death was observed in the IVUS group, which was related to a respiratory infection. No myocardial infarction or stent thrombosis was observed in either group. Kaplan-Meier estimates of cumulative freedom from MACE during 12-month follow-up are shown in Figure 3 . 
Discussion
The major findings in the current study are: 1) FFR-or IVUS-guided PCI in patients with intermediate coronary lesions was associated with favorable clinical outcomes; and 2) the rate of performed PCI in intermediate coronary The FFR-and IVUS-guided groups demonstrated excellent 12-month clinical outcomes without significant between-group differences. All p values were Ͼ0.05. MACE ϭ major adverse cardiac event; MI ϭ myocardial infarction; TVR ϭ target vessel revascularization; other abbreviations as in Figure 1 . lesions was significantly lower in the FFR-guided compared with the IVUS-guided group without any increase of adverse event rates according to established criteria.
Assessment of a coronary lesion with intermediate severity remains challenging for interventional cardiologists. The clinical importance of a mild-to-moderate coronary stenosis has been increased by some who propose that acute myocardial infarctions originate from such lesions (13, 14) . Some argue that for this reason, PCI with DES might be beneficial for the patients with an intermediate coronary lesion (15, 16) . However, recent studies showed that stenting intermediate stenoses, without demonstrating their physiologic significance, does not improve outcome (5, 6) , and optimal medical treatment might result in similar outcomes (17) . In this study, the overall incidence of MACE at 1 year was very low, namely 3.4% (6 of 177 lesions). Although 36% (63 of 177 lesions) of cases were deferred, the MACE rate was similar or lower than the results of recent DES clinical trials. The MACE rate of the deferral group was 3.2% (2 of 63) and similar to that of the PCI group, which was 3.5% (4 of 114). In a pooled analysis in which outcomes after DES were evaluated from 4 randomized trials (16), the MACE rate of DES is similar or even higher than that of FFR-or IVUS-guided deferral group in the current study. Therefore, FFR or IVUS measurements can be helpful in guiding the clinical decision process in patients with doubtful angiographic severity by reducing unnecessary stenting without increasing adverse clinical events.
By multivariate regression analysis, performing intervention was more frequent in the IVUS-guided group, in an LAD lesion, or in patients with multivessel disease. The last 2 factors seem intuitive, because the LAD territory has a large burden of myocardium compared with that of other major coronary arteries, and multivessel disease patients have a higher chance of having a significant lesion, whether assessed by IVUS or FFR. In the current study, the rate of PCI was 3 times higher in the IVUS-guided group than in the FFR-guided group. However, the MACE rate was not different between the 2 groups. Although there have been several studies reporting a good correlation between FFRand IVUS-derived MLA for assessing coronary lesions (7, 18) , the cutoff point based on MLA Ͻ4.0 mm 2 does not reflect the location of a lesion or the amount of myocardium subtended by the vessel. When the rate of PCI was reanalyzed according to reference vessel diameter (Ն3.0 mm or Ͻ3.0 mm) or lesion location (proximal or mid), the results did not change. Therefore, IVUS can overestimate the clinical significance of intermediate coronary lesions (19) and likely explains the increased rate of PCI in this group. If MLA Ͻ3.0 mm 2 was applied for the cutoff point in the current study, as previously reported (20) , the incidence of performing PCI might be decreased to 42.6%, similar to that of the FFR-guided group. When a cut-point was used that resulted in equal PCI rates of FFR group, MLA 2.5 mm 2 was the most indicated value. Unfortunately, this retrospective pilot study was not powered to detect a difference in clinical outcome. With larger numbers, one might anticipate that the excess PCI in the IVUSguided group would translate into an increase in the adverse event rate. This study further confirms the safety of deferring PCI in nonischemia-producing lesions (21) . Study limitations. First, it was a retrospective study. There were several different baseline characteristics such as a higher incidence of single-vessel disease and larger reference vessel diameter in the IVUS group. Second, the decision to select IVUS or FFR was left at the discretion of the operators. Although there was no statistically significant ACS ϭ acute coronary syndrome; CI ϭ confidence interval; VD ϭ vessel disease; other abbreviations as in Table 1 . Nam et al.
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difference of selection of guided method between operators, this study's results are subject to selection bias. It is not a direct comparison of IVUS and FFR within the same patients, attempting to see which patients would be acceptable for PCI using each technology. Third, the number of patients included in the study was small and the duration of the follow-up was relatively short considering the low event rate at 1-year follow-up. Therefore, these results should be confirmed by larger randomized studies with a longer follow-up period. Fourth, the consequences of the multivariate test could be overfitted, because the parameters were selected when p value was Ͻ0.5 in univariate analysis.
Conclusions
Both FFR-and IVUS-guided PCI for intermediate coronary artery disease were associated with favorable outcomes. The FFR-guided PCI reduces the need for revascularization of many of these lesions.
